(Press-News.org) July 14, 2015 - More than 80 percent of people with depression in the general population aren't eligible for clinical trials of antidepressant drugs, according to a study in the Journal of Psychiatric Practice. The journal is published by Wolters Kluwer.
At least five patients would need to be screened to enroll just one patient meeting the typical inclusion and exclusion criteria for antidepressant registration trials (ARTs), suggests the new research by Drs. Sheldon Preskorn and Matthew Macaluso of University of Kansas School of Medicine-Wichita and Dr. Madhukar Trivedi of Southwestern Medical School, Dallas. The study highlights some major differences between patients with depression seen in everyday clinical practice and those enrolled in ARTs--the studies of antidepressants that lead to FDA drug approval.
Most Patients with Major Depression Aren't Eligible for ARTs
Antidepressant registration trials use certain inclusion and exclusion criteria to create a group of patients with similar characteristics. These criteria increase the chances of detecting true drug effects, while reducing "false signals" of safety problems or side effects. For example, ARTs commonly exclude patients with other medical problems--if their illness worsened during the study, it might raise inaccurate safety concerns about the drug being studied.
To find out how these inclusion and exclusion criteria affect patient selection for ARTs, the researchers analyzed more than 4,000 patients from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Funded by the National Institute of Mental Health, STAR*D was the largest and longest study of depression treatment ever conducted. To ensure that the "real world" population of patients with depression was represented, STAR*D used minimal exclusion criteria.
The researchers found that more than 82 percent of STAR*D patients would not be eligible for enrollment in current ARTs, based on a list of "usual" inclusion and exclusion criteria. Fourteen percent would be excluded on the basis of age alone--that's because most ARTs exclude patients older than 65. Another 15 percent would be excluded because their depression was less severe than a commonly used cutoff point.
More than 20 percent of STAR*D patients would be excluded from ARTs because of a "clinically significant or unstable general medical condition." Twenty-one percent of women would be excluded because they were not using birth control to prevent pregnancy during the study.
Because many ARTs use stricter criteria, the true exclusion rate is probably even higher, the authors note. For example, more recent studies have used even higher severity thresholds for enrollment, which would eliminate more than 90 percent of the STAR*D population. The researchers also point out that all of the STAR*D patients had obviously agreed to participate in that research study--which is something many people with depression might be unwilling to do.
The researchers hope their work will help drug developers understand how inclusion and exclusion criteria may affect enrollment in ARTs, and help them in developing an appropriate recruitment plan and timeline. "The timelines in most drug studies are unrealistically short and their recruitment plans are often woefully inadequate, resulting in studies that take longer than expected to complete and frequent budget overruns," Drs. Preskorn, Macaluso, and Trivdei write. Failure to consider the effort needed for ART recruitment might lead to lost revenue, delays in bringing a drug to market, or failure to develop a potentially effective medication.
The findings may also help to explain to healthcare practitioners why ARTs tend to overestimate the benefits of antidepressant treatment in "real world" patients with depression. "Obviously," the researchers add, "the more patients who are excluded from the ARTs, the greater the chances that the results will not generalize to the routine clinical practice."
INFORMATION:
Click here to read "How Commonly Used Inclusion and Exclusion Criteria in Antidepressant Registration Trials Affect Study Enrollment."
Article: "How Commonly Used Inclusion and Exclusion Criteria in Antidepressant Registration Trials Affect Study Enrollment" (doi: 10.1097/PRA.0000000000000082)
About Journal of Psychiatric Practice
Journal of Psychiatric Practice®, a peer reviewed journal, publishes reports on new research, clinically applicable reviews, articles on treatment advances, and case studies, with the goal of providing practical and informative guidance for clinicians. Mental health professionals will want access to this journal--for sharpening their clinical skills, discovering the best in treatment, and navigating this rapidly changing field. John M. Oldham, MD, is the editor in chief and past president of the American Psychiatric Association.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information about our products and organization, visit http://www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.
July 14, 2015 - Benzodiazepine drugs are widely used in patients with posttraumatic stress disorder (PTSD), but available evidence suggests that they are not effective--and may even be harmful, concludes a systematic review and meta-analysis in the July Journal of Psychiatric Practice. The journal is published by Wolters Kluwer.
"Benzodiazepines are ineffective for PTSD treatment and prevention, and risks associated with their use tend to outweigh potential short-term benefits," write Dr. Jeffrey Guina and colleagues from Wright State University, Dayton, Ohio. They also ...
Collision physics can be like a game of billiards. Yet in the microscopic world, the outcome of the game is hard to predict. Fire a particle at a group of other particles, and they may scatter, combine or break apart, according to probability distributions governed by quantum mechanics. These processes can tell us about fundamental properties of matter and, if antimatter projectiles are used, also about matter-antimatter interactions.
Scientists at UCL have finally answered one of the basic questions that has remained outstanding until now: if, in a collision with matter, ...
CHICAGO-- Algae is evolving as the next new alternative protein source consumers are anxious to bite into as an ingredient in crackers, snack bars, cereals and breads, according to a July 12th presentation at IFT15: Where Science Feeds Innovation hosted by the Institute of Food Technologists (IFT) in Chicago.
Algae, quinoa and pulses are considered by some food technologists to be the best protein sources and strong alternatives to slow meat consumption, reduce food waste and help feed the world's growing population.
Algae is a new vegan source of protein with a comparable ...
Recent research has warned of the health detriments associated with sitting for long stretches of time at the office, but what about the nearly half of all employees worldwide who are required to stand for more than 75% of their workdays? Prolonged standing is associated with short-term adverse health issues, including reports of fatigue, leg cramps, and backaches, which can affect job performance and cause significant discomfort. A new study published in Human Factors suggests that, over time, this type of sustained muscle fatigue can result in serious health consequences.
"The ...
James Cook University researchers are creating a buzz in bee research, gluing tiny transmitters to the backs of the insects for the first time.
Lead researcher, JCU's Dr Lori Lach, said the team glued Radio-Frequency Identification (RFID) chips to the backs of 960 bees, providing new insights into how disease affects the threatened insects.
"We just had to hold them in our hands and hope the glue dried quickly. It was actually quite a process - they had to be individually painted, then individually fed, then the tag glued on. Then individually scanned so we knew which ...
A new report to state lawmakers on hydraulic fracturing in California provides an important road map for scientists as they strive to produce energy while protecting human health and the environment, according to a scientist with appointments at University of the Pacific and Lawrence Berkeley National Laboratory.
William T. Stringfellow, director of the Environmental Measurements Laboratory at Lawrence Berkeley and a professor of engineering at Pacific, was part of a team of scientists who prepared the state-mandated independent assessment of oil well stimulation treatments, ...
PITTSBURGH, July 14, 2015 - People diagnosed with type 1 diabetes in later childhood have weaker brain connectivity in midlife compared to those who were diagnosed at earlier ages according to a University of Pittsburgh Schools of the Health Sciences study.
The findings are reported in a special issue of Psychosomatic Medicine that is focused on diabetes, obesity and the brain. Sixty-six middle-aged adults (ages 32 to 58) who were diagnosed with type 1 diabetes as children participated in the study.
"Other studies have shown an association between earlier onset ...
As part of the Government's Summer Budget, the Chancellor, George Osborne, confirmed funding for six new multidisciplinary research centres - worth a total of £45 million with partner contributions - that will drive forward the UK's Digital Economy research, knowledge and skills.
Designed to help create and deliver real-world impact, the £23 million investment will come via The Engineering and Physical Sciences Research Council (EPSRC) and will support the centres over the next five years.
The centres will be hosted by the Universities of York, Bath, and ...
How heat travels, matters. Yet, there is still no consensus on the exact physical mechanism that causes anomalous heat conduction - despite the existence of previous numerical simulation, theoretical predictions and experimental observations. Now, a team based in Asia has demonstrated that electron transport depends on temperature. It follows a scaling governed by a power law - and not the exponential scaling previously envisaged. These findings were recently published in EPJ B by Yunyun Li Tongji University, Shanghai, China, and colleagues in Singapore.
Heat conduction ...
Kyoto, Japan - A group led by Assistant Professor Dan Ohtan Wang from Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS) in Japan successfully visualized RNA behavior and its response to drugs within the living tissue brain of live mice by labeling specific RNA molecules with fluorescent probes. Their study, published in Nucleic Acids Research, can potentially lead to faster, and more accurate screening processes for the discovery and development of new drugs.
RNA is a molecule that plays a key role within a living organism, holding information ...
